Clinical, paraclinical and bacteriological characteristics in hospitalized patients with acute exacerbation of bronchiectasis

  • Nguyễn Văn Sơn Bệnh viện Trung ương Quân đội 108
  • Nguyễn Xuân Dũng Bệnh viện Trung ương Quân đội 108
  • Nguyễn Minh Hải Bệnh viện Trung ương Quân đội 108
  • Thi Thị Duyên Bệnh viện Trung ương Quân đội 108
  • Nguyễn Tuệ Minh Bệnh viện Trung ương Quân đội 108
  • Lê Hữu Ý Bệnh viện Trung ương Quân đội 108

Main Article Content

Keywords

Acute exacerbations, bronchiectasis, bronchoaveolar lavage fluid, bacteriology

Abstract

Objective: To describe the clinical and laboratory features, as well as the bacteriological characteristics in bronchoaveolar lavage fluid in hospitalized patients with acute exacerbation of bronchiectasis. Subject and method: A descriptive cross-sectional study was conducted involving 122 patients diagnosed with acute exacerbation of bronchiectasis. Among them, bronchoscopy was performed in 60 patients to collect bronchoaveolar lavage fluid for microbiological culture analysis. Additionally, sputum samples were collected, cultured, and compared with the results of bronchoaveolar lavage fluid cultures. Result: Male patients accounted for 51.6%, with an average age of 68.09 ± 10.86 years. Patients presented a notable prevalence of history of pulmonary tuberculosis and underlying comorbidities. Common symptoms included cough, sputum, dyspnea, and crackles upon lung examination. On average, patients experienced 1.88 ± 1.43 exacerbations per year requiring hospitalization. HRCT revealed diffuse dilatation involvement in 82.8% of cases. Patients with underlying diseases and diffuse lesion on HRCT had a significantly higher frequency of ≥ 2 exacerbations per year compared to those without comorbidities and local lesion on HRCT with p<0.05. Microbiological analysis demonstrated positive culture rates of 86.7% in bronchoaveolar lavage fluid samples and 96% in sputum samples. Gram-negative bacteria were isolated, with Pseudomonas aeruginosa, Escherichia coli, and Acinetobacter baumannii being the most frequently identified pathogens. There was no significant differences in bacteriological distribution between patients experiencing ≥ 2 exacerbations per year compared to those with fewer exacerbations. Conclusion: Patients experiencing acute exacerbations of bronchiectasis upon hospitalization commonly exhibit a history of pulmonary tuberculosis and a significant prevalence of underlying diseases, mainly with diffuse lesions, frequently require multiple hospitalizations per year. Gram-negative bacteria were most frequently identified pathogens, and still sensitive to several types of antibiotics.

Article Details

References

1. Nguyễn Đình Tiến và Nguyễn Minh Hải (2020) Giãn phế quản. Bệnh hô hấp. Nhà xuất bản Y học, Hà Nội, tr. 117-125.
2. Choi H, Chalmers JD (2023) Bronchiectasis exacerbation: A narrative review of causes, risk factors, management and prevention. Ann Transl Med 11(1): 25.
3. Amati F, Simonetta E, Gramegna A et al (2019) The biology of pulmonary exacerbations in bronchiectasis. Eur Respir Rev 28(154): 190055.
4. Finch S, McDonnell MJ, Abo-Leyah H et al (2015) A comprehensive analysis of the impact of pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Ann Am Thorac Soc 12(11): 1602-1611.
5. Bronchiectasis News Today Antibiotics for Bronchiectasis Treatment. https://bronchiectasisnewstoday.com/antibiotics-for-bronchiectasis-treatment/ (truy cập ngày 28 tháng 4 năm 2024).
6. Kim HC, Suzuki M, Lim HF et al (2021) Survey of the management of patients with bronchiectasis: a pilot investigation in Asian populations. Korean J Intern Med 36(6): 1402-1409.
7. Hill AT, Haworth CS, Aliberti S et al (2017) Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J 49(6):1700051.
8. Chu Thị Thu Lan (2016) Đặc điểm lâm sàng, hình ảnh chụp cắt lớp vi tính độ phân giải cao và vi khuẩn học qua dịch rửa phế quản tại Bệnh viện Trung ương Thái Nguyên. Luận văn Thạc sĩ Y học, Trường Đại Học Y Hà Nội.
9. Ringshausen FC, Roux AD Diel R et al (2015) Bronchiectasis in Germany: A population-based estimation of disease prevalence. Eur Respir J 46(6): 1805-1807.
10. Le HY, Le VN, Pham NH et al (2020) Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: A prospective study. BMC Pulm Med 20(1): 231.
11. Chu Khánh Hòa (2015) Đặc điểm lâm sàng, cận lâm sàng và vi khuẩn học của bệnh nhân giãn phế quản tại Trung tâm Hô hấp, Bệnh viện Bạch Mai. Khóa luận tốt nghiệp bác sỹ đa khoa, Trường Đại học Y Hà Nội.
12. Moreira JDS, Porto NDS, Peixoto JDJ et al (2003) Bronchiectasis: Diagnostic and therapeutic features A study of 170 patients. J. Pneumologia 29 (5): 258-263.
13. King PT, Holdsworth SR, Freezer NJ et al (2007) Microbiologic follow-up study in adult bronchiectasis. Respir Med 101(8): 1633-1638.
14. Santamaria F, Montella S, Camera L et al (2006) Lung structure abnormalities, but normal lung function in pediatric bronchiectasis. Chest 130(2): 480-486.
15. McDonnell MJ, Jary HR, Perry A et al (2015) Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance. Respir Med 109(6): 716-726.
16. Evans SA, Turner SM, Bosch BJ et al (1996) Lung function in bronchiectasis: The influence of Pseudomonas aeruginosa. Eur Respir J 9(8): 1601-164.
17. Vallières E, Tumelty K, Tunney MM et al (2017) Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis. Eur Respir J 49(4): 1600851.
18. Sethi GR and Batra V (2000) Bronchiectasis : Causes and management. Indian J Pediatr 67(2): 133-139.